![](http://www.alamy.com/thumbs/6/05D23A62-694D-4BCC-8D19-B0719074B218/2ADG73X.jpg)
Process engineer monitors production-scale bioreactors containing insect cell cultures for the production of VaxSyn, an experimental AIDS vaccine. The
Process engineer monitors production-scale bioreactors containing insect cell cultures for the production of VaxSyn, an experimental AIDS vaccine. The vaccine is an engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn is genetically-engineered from the baculovirus (an insect virus), with insect cell cultures used in the scale-up process. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV- positive patients & as a potential vaccine against HIV infection.
Size: 3851px × 2480px
Photo credit: © HANK MORGAN/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: aids, bioengineered, bioengineering, bioreactor, biotechnology, drug, drugs, experimental, genetic, genetics, manufacture, production, vaccine, vaxsyn